![]() |
|
|
Vol. 288, Issue 2, 858-865, February 1999
Quebec Heart Institute, Treatment with second generation histamine H1 receptor antagonists has
been associated with lengthening of the Q-T interval and proarrhythmia.
Similarly, lengthening of the Q-T interval has been reported in
patients after overdosing with diphenhydramine (DPH), a first
generation agent. Therefore, our study was designed 1) to assess
effects of DPH on cardiac repolarization and 2) to characterize effects
of the drug on major voltage-dependent cardiac K+ currents.
First, we noticed that oral administration of DPH at usual dosages to
healthy volunteers or to patients (prior to angioplasty) was associated
with prolongation of the Q-Tc interval. Although this
effect was modest in most individuals, Q-Tc was increased more than 20 ms in 7 of 20 patients. Second, we noticed that exposure of isolated guinea pig hearts to DPH 10
5 M caused a
lengthening of monophasic action potential duration. This effect was
potentiated by the combined perfusion of other K+ channel
blockers such as indapamide. Finally, experiments performed with the
patch-clamp technique demonstrated unequivocal block of the rapid
component of the delayed rectifier (IKr) by DPH; however,
IC50 determined for block of IKr (3 · 10
5 M) is ~40-fold greater than plasma concentrations
of the drug measured at usual dosages (7 · 10
7 M).
Consequently, in agreement with the long-term clinical use of the drug,
prolongation of cardiac repolarization should be minimal in most
patients at usual dosages but may be observed with overdosing.
Nevertheless, caution remains since excessive lengthening of cardiac
repolarization may occur after administration of DPH with other drugs
due to 1) concomitant block of other ionic currents or 2)
pharmacokinetic interactions leading to toxic concentrations of DPH.
0022-3565/99/2882-0858$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
A. K. Peters, M. Steemans, E. Hansen, N. Mesens, G. R. Verheyen, and P. Vanparys Evaluation of the Embryotoxic Potency of Compounds in a Newly Revised High Throughput Embryonic Stem Cell Test Toxicol. Sci., October 1, 2008; 105(2): 342 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Guth Preclinical Cardiovascular Risk Assessment in Modern Drug Development Toxicol. Sci., May 1, 2007; 97(1): 4 - 20. [Full Text] [PDF] |
||||
![]() |
A. Sharma, P. Pibarot, S. Pilote, J. G. Dumesnil, M. Arsenault, P. M. Belanger, B. Meibohm, and B. A. Hamelin Modulation of Metoprolol Pharmacokinetics and Hemodynamics by Diphenhydramine Coadministration during Exercise Testing in Healthy Premenopausal Women J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1172 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hamlin, A. Kijtawornrat, B. W. Keene, and D. M. Hamlin QT and RR Intervals in Conscious and Anesthetized Guinea Pigs with Highly Varying RR Intervals and Given QTc-Lengthening Test Articles Toxicol. Sci., December 1, 2003; 76(2): 437 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gralinski The Dog's Role in the Preclinical Assessment of QT Interval Prolongation Toxicol Pathol, January 1, 2003; 31(1_suppl): 11 - 16. [Abstract] [PDF] |
||||
![]() |
B. Drolet, G. Rousseau, P. Daleau, R. Cardinal, and J. Turgeon Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders Circulation, October 17, 2000; 102(16): 1883 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drolet, A. Emond, B. Pharm, V. Fortin, P. Daleau, G. Rousseau, R. Cardinal, and J. Turgeon Vitamin K Modulates Cardiac Action Potential by Blocking Sodium and Potassium Ion Channels Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 267 - 273. [Abstract] [PDF] |
||||